Short-Term Low Dose Cannabidiol Does Not Influence Glucose Tolerance or the Gut Microbiome in Sedentary Adults with Overweight and Obesity: Pilot Study
Short-term daily ingestion of low-dose CBD did not appear to favorably modify glucose tolerance in sedentary adults with overweight or obesity. It is possible that CBD may not account for the previously reported protection from type 2 diabetes bestowed to regular users of cannabis products.
Authors
- Natasha Williams (ORCID: https://orcid.org/0000-0002-9267-6520)
- Christopher Bell (ORCID: https://orcid.org/0000-0002-7706-0912)
- Gregory Dooley (ORCID: https://orcid.org/0000-0002-3296-0300)
- Tiffany L. Weir (ORCID: https://orcid.org/0000-0001-5423-7140)
- Matthew C. Bomar
- Briana Risk (ORCID: https://orcid.org/0000-0002-8096-6993)
- Kieran Shay Struebin Abbotts (ORCID: https://orcid.org/0000-0001-5451-6369)
- Taylor R. Ewell (ORCID: https://orcid.org/0000-0001-8220-9745)
- Yuren Wei
- Brendan T. Kayne
Institutions
- Colorado State University (US)
Publication Details
- Journal
- Cannabis and Cannabinoid Research
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1177/25785125251391085
- Citations
- 1
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39